On June 11, the World Prostate Cancer Day and, for that reason, the Spanish Society of Radiation Oncology has highlighted the significance of radiotherapy as a healing therapy for one of these most cancers. The renovation of the nationwide know-how park lately has allowed implement new methods of stereotaxic physique radiation remedy or SBRT and thus scale back the variety of radiotherapy periods, sustaining the very excessive treatment charges of this tumor, with out altering the standard of lifetime of sufferers. As well as, within the final 12 months it has begun to utilizing radiation remedy in folks with metastatic illness, which has led to a big enchancment within the survival of those sufferers.
In Spain 35,126 new instances of prostate most cancers had been recognized in 2020. It’s the commonest tumor in males and the third explanation for most cancers mortality, with greater than 5,000 deaths yearly. Nonetheless, survival has elevated lately due to improved therapies. Certainly one of them is radiotherapy.
Radiation remedy is a well-established healing therapy for localized prostate most cancers. In tumors with unfavorable or high-risk prognostic components, the mixed therapy of radiotherapy and hormonal therapy (androgen deprivation remedy) is presently the usual method.
New eventualities for radiation oncology
Dr. Alfonso Gómez-Iturriaga, coordinator of the urological tumors group (UroncOR) of the SEOR, and radiation oncologist on the College Hospital of Cruces (Vizcaya), explains that, due to the renovation of the nationwide radiotherapy know-how park and promoted by the stress of the pandemic, “they’ve began new therapy methods in prostate most cancers. A lot of hospitals have carried out stereotaxic physique radiotherapy or SBRT methods, which make it potential to cut back the variety of radiotherapy periods from 20-25 to solely 5. As well as, the very excessive treatment charges of this tumor are maintained, with out altering the standard lifetime of sufferers ”.
One other of probably the most notable modifications that Radiation Oncology has skilled within the therapy of prostate most cancers over the last 12 months is the appliance of radiotherapy in sufferers with metastatic illness. Many of those sufferers, who traditionally had been handled completely with pharmacological therapies, can now be profit from radiotherapy in native therapies on his prostate tumor, thus permitting better native management of the illness and a big enchancment in survival.
Gómez-Iturriaga factors out that “a secondary evaluation of the STAMPEDE examine, lately offered on the American Congress of Uro-Oncology, has proven that the sufferers who profit probably the most from native therapy of the prostate with radiotherapy are these with three or fewer metastases.”
However, the state of affairs skilled by most hospitals because of the SARS-CoV-2 pandemic has made it essential to make essential selections that could influence the routine administration of most cancers sufferers.
Gómez-Iturriaga factors out that “in prostate most cancers, precedence has been given to utilizing shorter therapy schemes, additionally known as hypofractionations, ideally primarily based on proof, relying on the chance group of every affected person and considering the infrastructure of every middle.” And he provides that on this state of affairs it’s “essential to make use of schemes that maximize effectivity. On this sense, in prostate most cancers there’s nice proof on the efficacy and security of hypofractionated schemes ”.